Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    December 2018
  1. JIANG M, Zou X, Lu L
    Potential efficacy and prognosis of silencing the CRLF2mediated AKT/mTOR pathway in pediatric acute Bcell lymphoblastic leukemia.
    Oncol Rep. 2018 Dec 7. doi: 10.3892/or.2018.6917.
    PubMed     Text format     Abstract available


  2. FU J, Si L, Zhuang Y, Zhang A, et al
    Wnt/betacatenin inhibition reverses multidrug resistance in pediatric acute lymphoblastic leukemia.
    Oncol Rep. 2018 Dec 4. doi: 10.3892/or.2018.6902.
    PubMed     Text format     Abstract available


    November 2018
  3. JING W, Li J
    Identification of biomarkers for the prediction of relapsefree survival in pediatric Bprecursor acute lymphoblastic leukemia.
    Oncol Rep. 2018 Nov 2. doi: 10.3892/or.2018.6846.
    PubMed     Text format     Abstract available


  4. ZHANG C, Guo LY, Mu D, Gong JH, et al
    Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
    Oncol Rep. 2018 Nov 2. doi: 10.3892/or.2018.6849.
    PubMed     Text format     Abstract available


    October 2018
  5. RYU I, Ryu MJ, Han J, Kim SJ, et al
    LDeprenyl exerts cytotoxicity towards acute myeloid leukemia through inhibition of mitochondrial respiration.
    Oncol Rep. 2018 Oct 1. doi: 10.3892/or.2018.6753.
    PubMed     Text format     Abstract available


    September 2018
  6. ZHAO W, Wang L, Yu Y
    Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs.
    Oncol Rep. 2018 Sep 18. doi: 10.3892/or.2018.6709.
    PubMed     Text format     Abstract available


  7. PANG X, Wang Y, Zhang S, Tan Z, et al
    Altered susceptibility to apoptosis and Nglycan profiles of hematopoietic KG1a cells following coculture with bone marrowderived stromal cells under hypoxic conditions.
    Oncol Rep. 2018;40:1477-1486.
    PubMed     Text format     Abstract available


    August 2018
  8. ZHAO Y, Zhong L, Liu L, Yao SF, et al
    Salinomycin induces apoptosis and differentiation in human acute promyelocytic leukemia cells.
    Oncol Rep. 2018;40:877-886.
    PubMed     Text format     Abstract available


    June 2018
  9. YU J, Guo XL, Bai YY, Yang JJ, et al
    Genomewide profiling of lncRNA expression patterns in patients with acute promyelocytic leukemia with differentiation therapy.
    Oncol Rep. 2018 Jun 25. doi: 10.3892/or.2018.6521.
    PubMed     Text format     Abstract available


  10. ZHANG XH, Yang L, Liu XJ, Zhan Y, et al
    Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia.
    Oncol Rep. 2018 Jun 19. doi: 10.3892/or.2018.6508.
    PubMed     Text format     Abstract available


    May 2018
  11. ZOVKO A, Yektaei-Karin E, Salamon D, Nilsson A, et al
    Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
    Oncol Rep. 2018 May 25. doi: 10.3892/or.2018.6465.
    PubMed     Text format     Abstract available


    April 2018
  12. CHEN N, Feng L, Qu H, Lu K, et al
    Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6367.
    PubMed     Text format     Abstract available


    February 2018
  13. MA X, Zhou X, Qu H, Ma Y, et al
    TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells.
    Oncol Rep. 2018 Feb 7. doi: 10.3892/or.2018.6249.
    PubMed     Text format     Abstract available


  14. DONG L, Xu WW, Li H, Bi KH, et al
    In vitro and in vivo anticancer effects of marmesin in U937 human leukemia cells are mediated via mitochondrial-mediated apoptosis, cell cycle arrest, and inhibition of cancer cell migration.
    Oncol Rep. 2018;39:597-602.
    PubMed     Text format     Abstract available


    January 2018
  15. LI GY, Liu JZ, Zhang L, Liu GZ, et al
    Knockdown of immature colon carcinoma transcript 1 induces suppression of proliferation, S-phase arrest and apoptosis in leukemia cells.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6185.
    PubMed     Text format     Abstract available


  16. LEE KW, Um ES, Jung BB, Choi ES, et al
    Rhus verniciflua Stokes extract induces inhibition of cell growth and apoptosis in human chronic myelogenous leukemia K562 cells.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6179.
    PubMed     Text format     Abstract available


  17. HUANG R, Liu H, Chen Y, He Y, et al
    EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.
    Oncol Rep. 2018;39:119-128.
    PubMed     Text format     Abstract available


    December 2017
  18. LIN MW, Yang JS, Lu CC, Lin C, et al
    2-Phenyl-4-quinolone (YT-1) induces G2/M phase arrest and an intrinsic apoptotic mechanism in human leukemia cells.
    Oncol Rep. 2017 Dec 20. doi: 10.3892/or.2017.6170.
    PubMed     Text format     Abstract available


    November 2017
  19. YANG JS, Lee CY, Cho HC, Lu CC, et al
    ITR284 modulates cell differentiation in human chronic myelogenous leukemia K562 cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6090.
    PubMed     Text format     Abstract available


    September 2017
  20. SHEN Y, Liu Q, Lou S, Luo Y, et al
    Decreased expression of the augmenter of liver regeneration results in growth inhibition and increased chemosensitivity of acute T lymphoblastic leukemia cells.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5984.
    PubMed     Text format     Abstract available


    July 2017
  21. HUANG JL, Liu W, Tian LH, Chai TT, et al
    Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia.
    Oncol Rep. 2017 Jul 10. doi: 10.3892/or.2017.5802.
    PubMed     Text format     Abstract available


    June 2017
  22. HAN XJ, Shi SL, Wei YF, Jiang LP, et al
    Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells.
    Oncol Rep. 2017 Jun 28. doi: 10.3892/or.2017.5765.
    PubMed     Text format     Abstract available


  23. JI Y, Ma Y, Chen X, Ji X, et al
    Microvesicles released from human embryonic stem cell derived-mesenchymal stem cells inhibit proliferation of leukemia cells.
    Oncol Rep. 2017 Jun 16. doi: 10.3892/or.2017.5729.
    PubMed     Text format     Abstract available


  24. LIU Y, Shin DY, Oh S, Kim S, et al
    KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5688.
    PubMed     Text format     Abstract available


  25. KONG X, Luo J, Xu T, Zhou Y, et al
    Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.
    Oncol Rep. 2017;37:3423-3432.
    PubMed     Text format     Abstract available


  26. KIM DM, Jang H, Shin MG, Kim JH, et al
    beta-catenin induces expression of prohibitin gene in acute leukemic cells.
    Oncol Rep. 2017;37:3201-3208.
    PubMed     Text format     Abstract available


    May 2017
  27. ZHOU HR, Fu HY, Wu DS, Zhang YY, et al
    Relationship between epigenetic changes in Wnt antagonists and acute leukemia.
    Oncol Rep. 2017;37:2663-2671.
    PubMed     Text format     Abstract available


    March 2017
  28. CHEN JR, Jia XH, Wang H, Yi YJ, et al
    With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
    Oncol Rep. 2017 Mar 29. doi: 10.3892/or.2017.5535.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: